ERYTECH Requested a Pre-BLA Meeting with the FDA to Discuss Path to Approval in ALL

NEXT STORY
Steba Biotech Treats First Patient in Pivotal ENLIGHTED Study of Padeliporfin ImPACT in Low Grade Upper Tract Urothelial Cancer
PREV STORY
Press release Biocartis Group NV: Biocartis Announces US FDA 510(k) submission of its Idylla™ MSI Test
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Generic Solid Dosage Forms Report: Competitive Picture for Generic Tablets and Capsules in Two Dozen Drug Classes

Dublin, Feb. 02, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition ...

author_avatar
NASDAQ Market News

Junshi Biosciences and Coherus Announce U.S. FDA Breakthrough Therapy Designation Granted for Toripalimab for 1st Line Treatment of Nasopharyngeal Carcinoma

author_avatar
NASDAQ Market News

RespireRx Pharmaceuticals Inc. Announces Participation SLEEP 2017 in Boston, MA

GLEN ROCK, NJ--(Marketwired - Jun 6, 2017) - RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ("RespireRx" ...

author_avatar
NASDAQ Market News